Literature DB >> 4051118

Melanoma metastatic to cervical and parotid nodes from an unknown primary site.

H Santini, R M Byers, P F Wolf.   

Abstract

The medical records of 96 patients with melanoma metastatic to cervical and parotid nodes from an unknown primary site have been reviewed. The use of various surgical procedures were correlated with local recurrence and survival rates. The size and number of involved nodes and the extent of nodal disease were compared with the type of treatment, and the age and sex of the patients, incidence of above-clavicle recurrence, and the 2, 5, and 10 year survival rates. The only significant correlations were the adverse affects of patient age over 50 years and multiple, large, pathologically positive nodes on local control and survival. Adjunctive chemotherapy and immunotherapy had no therapeutic value.

Entities:  

Mesh:

Year:  1985        PMID: 4051118     DOI: 10.1016/0002-9610(85)90165-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  Malignant melanoma of parotid gland in a child-our unique experience.

Authors:  Denish Apparau; Hema Apparau; Irfan Mohamad; Venkata Murali Krishna Bhavaraju
Journal:  AME Case Rep       Date:  2018-02-02

2.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

Review 3.  Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A Single-Institution Study and Review of the Literature.

Authors:  Kierstin Utter; Chloe Goldman; Sarah A Weiss; Richard L Shapiro; Russell S Berman; Melissa Ann Wilson; Anna C Pavlick; Iman Osman
Journal:  Oncology       Date:  2017-07-27       Impact factor: 2.935

Review 4.  [Primary malignant melanoma of the parotid gland: a case report and review of the literature].

Authors:  H Maier; G Mühlmeier; K Kraft; N M Blumstein; M Tisch
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

5.  Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014.

Authors:  Jeffrey F Scott; Ruzica Z Conic; Cheryl L Thompson; Meg R Gerstenblith; Jeremy S Bordeaux
Journal:  J Am Acad Dermatol       Date:  2018-03-23       Impact factor: 11.527

6.  Parotid melanoma of unknown primary.

Authors:  Jeffrey F Scott; Cheryl L Thompson; Ritva Vyas; Kord Honda; Chad Zender; Rod Rezaee; Pierre Lavertu; Henry Koon; Kevin D Cooper; Meg R Gerstenblith
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-13       Impact factor: 4.553

7.  Neck dissection and post-operative chemotherapy with dimethyl triazeno imidazole carboxamide and cisplatin protocol are useful for oral mucosal melanoma.

Authors:  Xi Yang; Guo-Xin Ren; Chen-Ping Zhang; Guo-Yu Zhou; Yong-Jie Hu; Wen-Jun Yang; Wei Guo; Jiang Li; Lai-Ping Zhong
Journal:  BMC Cancer       Date:  2010-11-11       Impact factor: 4.430

8.  Primary malignant melanoma of the parotid gland: A case report and review of the literature.

Authors:  Anass Chaouki; Omar Berrada; Zouhair Najib; Youssef Oukessou; Reda Allah Abada; Sami Rouadi; Mohammed Roubal; Mohammed Mahtar
Journal:  Ann Med Surg (Lond)       Date:  2020-12-01

9.  Treatment of Regional Metastatic Melanoma of Unknown Primary Origin.

Authors:  Elke J A H van Beek; Alfons J M Balm; Omgo E Nieweg; Olga Hamming-Vrieze; Peter J F M Lohuis; W Martin C Klop
Journal:  Cancers (Basel)       Date:  2015-08-10       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.